Market Cap

Celyad Oncology SA Market Capitalization:

$14.2 Million

USD as of July 1, 2023

business Celyad Oncology SA Company Profile

Celyad Oncology SA Main Stock Listing

NASDAQ: CYAD

Market Capitalization History of Celyad Oncology SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Celyad Oncology SA market cap

Date Market Cap YoY Change
Jan. 1, 2023 $53.5 M -44.73%
Jan. 1, 2022 $96.9 M -56.45%
Jan. 1, 2021 $222.5 M -25.37%
Jan. 1, 2020 $298.1 M -50.00%
Jan. 1, 2019 $596.2 M -53.92%
Jan. 1, 2018 $1.29 B 125.93%
Jan. 1, 2017 $572.7 M -40.90%
Jan. 1, 2016 $969.1 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Celyad Oncology SA Categories

Belgium languages Healthcare languages Biotechnology
Belgium Healthcare Belgium Biotechnology

Stocks & Indices

Celyad Oncology SA has the following listings and related stock indices.


Stock: NASDAQ: CYAD

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.